Profile
Jon Magne Asmyr served as the Chairman of Nordic Nanovector ASA in 2023.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
THOR MEDICAL ASA
1.99% | 2023-07-30 | 4,647,426 ( 1.99% ) | 444 852 $ | 2024-04-29 |
Former positions of Jon Asmyr
| Companies | Position | End |
|---|---|---|
| THOR MEDICAL | Chairman | 2023-06-27 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Nordic Nanovector ASA
 Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Nordic Nanovector ASA is a biopharmaceutical company, which engages in the development, marketing, and sale of medical products and equipment for anticancer therapeutics for haematological cancers. The firm offers the Betalutin which is an antibody radionuclide conjugates for the treatment of non-Hodgkin lymphoma. It operates through the following geographical segments: Norway, Switzerland, and the United Kingdom. The company was founded by Roy Hartvig Larsen, Oyvind Sverre Bruland, and Jostein Dahle on July 2, 2009 and is headquartered in Oslo, Norway. | Health Technology |
- Stock Market
- Insiders
- Jon Asmyr